Wells Fargo’s AC Immune ACIU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.08M Buy
1,024,608
+26,987
+3% +$54.8K ﹤0.01% 2889
2025
Q1
$1.87M Buy
997,621
+1,985
+0.2% +$3.71K ﹤0.01% 2858
2024
Q4
$2.69M Sell
995,636
-112,402
-10% -$303K ﹤0.01% 2598
2024
Q3
$4.19M Sell
1,108,038
-13,979
-1% -$52.8K ﹤0.01% 2242
2024
Q2
$4.48M Buy
1,122,017
+2,314
+0.2% +$9.23K ﹤0.01% 2143
2024
Q1
$3.31M Sell
1,119,703
-28,988
-3% -$85.8K ﹤0.01% 2326
2023
Q4
$5.74M Buy
1,148,691
+2,605
+0.2% +$13K ﹤0.01% 1913
2023
Q3
$3.27M Buy
1,146,086
+6,328
+0.6% +$18K ﹤0.01% 2263
2023
Q2
$3.37M Buy
1,139,758
+162,926
+17% +$481K ﹤0.01% 2351
2023
Q1
$2.29M Buy
976,832
+246,908
+34% +$578K ﹤0.01% 2586
2022
Q4
$1.49M Buy
729,924
+78,366
+12% +$160K ﹤0.01% 2817
2022
Q3
$2.06M Buy
651,558
+109,794
+20% +$347K ﹤0.01% 2566
2022
Q2
$1.96M Buy
541,764
+50,408
+10% +$182K ﹤0.01% 2666
2022
Q1
$1.97M Buy
491,356
+77,276
+19% +$309K ﹤0.01% 3128
2021
Q4
$2.05M Buy
414,080
+61,780
+18% +$306K ﹤0.01% 3260
2021
Q3
$2.36M Buy
352,300
+17,196
+5% +$115K ﹤0.01% 3343
2021
Q2
$2.66M Buy
335,104
+14,175
+4% +$112K ﹤0.01% 3274
2021
Q1
$2.44M Sell
320,929
-2,525
-0.8% -$19.2K ﹤0.01% 3322
2020
Q4
$1.67M Buy
323,454
+115,509
+56% +$597K ﹤0.01% 3575
2020
Q3
$1.02M Buy
207,945
+27,803
+15% +$136K ﹤0.01% 3772
2020
Q2
$1.21M Sell
180,142
-29,398
-14% -$198K ﹤0.01% 3581
2020
Q1
$1.45M Buy
209,540
+2,526
+1% +$17.5K ﹤0.01% 3194
2019
Q4
$1.76M Buy
207,014
+100
+0% +$852 ﹤0.01% 3408
2019
Q3
$1.02M Buy
206,914
+87,220
+73% +$432K ﹤0.01% 3763
2019
Q2
$664K Hold
119,694
﹤0.01% 4088
2019
Q1
$604K Buy
+119,694
New +$604K ﹤0.01% 4167
2018
Q1
Sell
-9,948
Closed -$127K 5867
2017
Q4
$127K Sell
9,948
-18
-0.2% -$230 ﹤0.01% 4989
2017
Q3
$111K Buy
+9,966
New +$111K ﹤0.01% 4971
2017
Q2
Sell
-250
Closed -$3K 5776
2017
Q1
$3K Hold
250
﹤0.01% 5665
2016
Q4
$3K Buy
+250
New +$3K ﹤0.01% 5649